Evidence map›Paper›PMID 28685052›Full record

ArticleBiomedical reports2017

Effect of dark-colored maple syrup on cell proliferation of human gastrointestinal cancer cell.

Tetsushi Yamamoto, Kanta Sato, Yuika Kubota, Kuniko Mitamura, Atsushi Taga

Open access · hybridAbstract read
In one paragraph

Article in Biomedical reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tetsushi YamamotoPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka 577-8502, Japan.
Kanta SatoPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka 577-8502, Japan.
Yuika KubotaPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka 577-8502, Japan.
Kuniko MitamuraPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka 577-8502, Japan.
Atsushi TagaPathological and Biomolecule Analyses Laboratory, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka 577-8502, Japan.
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maple syrup is a natural sweetener that is commonly consumed worldwide. While maple syrup mainly comprises sucrose, it also contains phytochemicals that present various biological effects. Maple syrup is made by boiling down sap, and its color and composition vary in accordance with the sap collection season. Typically, seasonal progression is associated with darker syrup color, and antioxidant activity is proportional to the increasingly dark color. The authors previously reported that maple syrup demonstrated inhibitory effects on colorectal cancer cell growth and invasion, which correlated with darker maple syrup color. In the present study, they examined the effects of two different grades of maple syrup on gastrointestinal cancer cell proliferation, to investigate whether the dark-color maple syrup was suitable as a phytomedicine for gastrointestinal cancer treatment. Administration of dark-color maple syrup significantly inhibited gastrointestinal cancer cell growth as compared to non-treated cancer cells. Moreover, administration of dark-color maple syrup clearly inhibited protein kinase B (AKT) phosphorylation and did not impact mitogen-associated protein kinase phosphorylation. These data suggested that dark-color maple syrup may inhibit cell proliferation through suppression of AKT activation and, thus, may be suitable as a phytomedicine for gastrointestinal cancer treatment.

Indexed as

cell proliferationgastrointestinal cancermaple syrupphytomedicineprotein kinase B

Identifiers

PMID28685052
PMCPMC5492655
OpenAlexW2615631470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.